Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623 · cited 1×
“Landmark secondary prevention studies (4S, CARE, LIPID) have provided strong evidence of the clinical benefits of LDL-lowering in people with diabetes [157, 158, 159].”
Background
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results From the Que´bec Cardiovascular Study
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels: Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Decreased IRS-2 and Increased SREBP-1c Lead to Mixed Insulin Resistance and Sensitivity in Livers of Lipodystrophic and ob/ob Mice
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 11×
“Adult Treatment panel III (ATP III) designated diabetes as a CHD risk equivalent and LDL was identified the first priority of lipid lowering [6].”
BackgroundInfluential
Management of Dyslipidemia in Adults With Diabetes
Haffner, S. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.160 · Cited by 786
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction
Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D. U., Piegas, L. S., Calvin, J. E., Keltai, M., Budaj, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.1014 · Cited by 746
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Steiner, G. A. (2001) · Cited by 732
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 719
High Density Lipoproteins and Arteriosclerosis
von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Impact of Diabetes on Mortality After the First Myocardial Infarction
Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665
Diabetic Dyslipidemia: Causes and Consequences
Goldberg, I. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7304 · Cited by 657
Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment
Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Da Ros, R., & Motz, E. (2002) · Circulation · doi:10.1161/01.cir.0000027569.76671.a8 · Cited by 655
The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes
Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study
de Vegt, F., Dekker, J. M., Ruhé, H. G., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (1999) · Diabetologia · doi:10.1007/s001250051249 · Cited by 611
Diabetes, Plasma Insulin, and Cardiovascular Disease: Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
[24] Nondenaturing polyacrylamide gradient gel electrophoresis
Nichols, A. V., Krauss, R. M., & Musliner, T. A. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28084-2 · Cited by 522
New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c
Foufelle, F., & Ferré, P. (2002) · Biochemical Journal · doi:10.1042/bj20020430 · Cited by 496
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490
Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
Tribble, D. L., Holl, L. G., Wood, P. D., & Krauss, R. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90255-f · Cited by 468
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431
Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Packard, C. J., & Shepherd, J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3542 · Cited by 408
Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance in Lep/Lep Mice
Yahagi, N., Shimano, H., Hasty, A. H., Matsuzaka, T., Ide, T., Yoshikawa, T., Amemiya-Kudo, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201584200 · Cited by 373
Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance
Taghibiglou, C., Carpentier, A. C., Iderstine, S. C. V., Chen, B., Rudy, D., Aiton, A., Lewis, G. F., & Adeli, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8416 · Cited by 346
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 331
Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals
Lewis, G. F., Uffelman, K. D., Szeto, L., & Steiner, G. A. (1993) · Diabetes · doi:10.2337/diab.42.6.833 · Cited by 323
The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
Tchernof, A., Lamarche, B., Prud'homme, D., Nadeau, A., Moorjani, S., Labrie, F., Lupien, P. J., & Després, J.-P. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.629 · Cited by 323
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Diabetologia · doi:10.1007/s001250050700 · Cited by 319
Self-citation
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
McFarlane, S. I., Muniyappa, R., Francisco, R., & Sowers, J. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8412 · Cited by 317
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
Feingold, K. R., Grünfeld, C., Pang, M., Doerrler, W. T., & Krauss, R. M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.12.1496 · Cited by 302
Mobilisation of triacylglycerol stores
Gibbons, G. F., Islam, K., & Pease, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00182-1 · Cited by 298
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 290
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women
Coresh, J., Kwiterovich, P., Smith, H., & Bachorik, P. S. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35731-x · Cited by 290
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Lipoprotein lipase in diabetes
Taskinen, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030208 · Cited by 273
Self-citation
Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease
Vakkilainen, J., Steiner, G. A., Ansquer, J.-C., Aubin, F., Rattier, S., Foucher, C., Hamsten, A., & Taskinen, M. (2003) · Circulation · doi:10.1161/01.cir.0000057982.50167.6e · Cited by 270
Self-citation
Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus
Syvänne, M., & Taskinen, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90024-6 · Cited by 266
Self-citation
Beyond lipid lowering: the role of statins in vascular protection
Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 263
Measurement issues related to lipoprotein heterogeneity
Otvos, J. D., Jeyarajah, E. J., & Cromwell, W. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02632-2 · Cited by 259
Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease
St-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., Bernard, P., Després, J., & Lamarche, B. (2001) · Circulation · doi:10.1161/hc4401.098490 · Cited by 259
Proatherogenic Role of Elevated CE Transfer From HDL to VLDL 1 and Dense LDL in Type 2 Diabetes
Guérin, M., Goff, W. L., Lassel, T. S., van Tol, A., Steiner, G. A., & Chapman, M. J. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.2.282 · Cited by 258
Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.
Schneeman, B. O., Kotite, L., Todd, K., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255 · cited 19×
“Of interest, apo CIII containing TRLs represent most triglyceride-rich species that are catabolized slowly [25, 26].”
BackgroundInfluential
Increased ABCA1 activity protects against atherosclerosis
Singaraja, R. R., Fievet, C., Castro, G., James, E. R., Hennuyer, N., Clee, S. M., Bissada, N., Choy, J. C., Fruchart, J.-C., McManus, B. M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15748 · Cited by 250
Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions
Onorato, J. M., Jenkins, A. J., Thorpe, S. R., & Baynes, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003263200 · Cited by 250
Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
Sehayek, E., & Eisenberg, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55263-7 · Cited by 249
The role of PPARs in atherosclerosis
Duval, C., Chinetti, G., Trottein, F., Fruchart, J., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 249
Impact of Diabetes on Long-Term Survival After Acute Myocardial Infarction
Mukamal, K. J., Nesto, R. W., Cohen, M. C., Muller, J. E., Maclure, M., Sherwood, J. B., & Mittleman, M. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1422 · Cited by 244
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
Packard, C. J., Demant, T., Stewart, J., Bedford, D. K., CASLAKE, M. J., Schwertfeger, G., Bedynek, A., Shepherd, J., & Seidel, D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32065-4 · Cited by 240
Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans
Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 237
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
Borén, J., Lee, I., Zhu, W., Arnold, K. S., Taylor, S., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1847 · Cited by 233
Lipoprotein glycation and its metabolic consequences
Lyons, T. J., & Jenkins, A. J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00008 · Cited by 232
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230
Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity
Galeano, N. F., Al-Haideri, M. T., Keyserman, F., Rumsey, S. C., & Deckelbaum, R. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32551-7 · Cited by 229
Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism
Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H. (2000) · Circulation · doi:10.1161/01.cir.102.6.670 · Cited by 227 · cited 1×
“In addition lipoproteins and remnants can also interact with coagulation factors [98, 99].”
Background
Ciprofibrate Therapy Improves Endothelial Function and Reduces Postprandial Lipemia and Oxidative Stress in Type 2 Diabetes Mellitus
Evans, M., Anderson, R. A., Graham, J. J., Ellis, G. R., Morris, K., Davies, S., Jackson, S. K., LEWIS, M. J., Frenneaux, M. P., & Rees, A. (2000) · Circulation · doi:10.1161/01.cir.101.15.1773 · Cited by 225
Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes
Fard, A., Tuck, C. H., Donis, J. A., Sciacca, R. R., Tullio, M. R. D., Wu, H. D., Bryant, T. A., Chen, N.-T., Torres‐Tamayo, M., Ramasamy, R., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2039 · Cited by 221
Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion
Sparks, J. D., & Sparks, C. E. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90088-4 · Cited by 217
Management of Dyslipidemia in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s83 · Cited by 206
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström, R., Packard, C. J., CASLAKE, M. J., Bedford, D. K., Stewart, P., Yki‐Järvinen, H., Shepherd, J., & Taskinen, M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.779 · Cited by 203
Self-citation
Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression.
Lin, M., Gordon, D., & Wetterau, J. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39865-5 · Cited by 196
Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara, T., Ramakrishnan, R., Steiner, G. A., & Shachter, N. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119456 · Cited by 195
Fasting and Postprandial Overproduction of Intestinally Derived Lipoproteins in an Animal Model of Insulin Resistance
Haidari, M., Leung, N., Mahbub, F., Uffelman, K., Kohen-Avramoglu, R., Lewis, G., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 191
Integrated Regulation of Very Low Density Lipoprotein Triglyceride and Apolipoprotein-B Kinetics in Non-insulin-dependent Diabetes Mellitus
Kissebah, A. H., Alfarsi, S., Evans, D. J., & ADAMS, P. W. (1982) · Diabetes · doi:10.2337/diab.31.3.217 · Cited by 190
Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity
Pascot, A., Lemieux, I., Prud’homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B., & Després, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31529-7 · Cited by 186
Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.
Galle, J., Mülsch, A., Busse, R., & Bassenge, E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.198 · Cited by 185
HDL metabolism in hypertriglyceridemic states: an overview
Lamarche, B., Rashid, S., & Lewis, G. F. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00098-4 · Cited by 184
Coronary Heart Disease in Patients With Low LDL-Cholesterol
Sacks, F. M., Tonkin, A. M., Craven, T. E., Pfeffer, M. A., Shepherd, J., KEECH, A. C., Furberg, C. D., & Braunwald, E. (2002) · Circulation · doi:10.1161/01.cir.0000012918.84068.43 · Cited by 184
Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size.
Galeano, N. F., Milne, R. W., Marcel, Y. L., Walsh, M. T., Levy, E. H., Ngu'yen, T. D., Gleeson, A. M., Arad, Y., Witte, L., & Al-Haideri, M. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42379-9 · Cited by 181
Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman, M. J., Guérin, M., & Bruckert, É. (1998) · PubMed · Cited by 178
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men
Malmström, R., Packard, C. J., Watson, T. D. G., Rannikko, S., CASLAKE, M. J., Bedford, D. K., Stewart, P., Yki‐Järvinen, H., Shepherd, J., & Taskinen, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1454 · Cited by 178
Self-citation
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy
Taskinen, M., Beltz, W. F., Harper, I., Fields, R. M., Schonfeld, G., Grundy, S. M., & Howard, B. V. (1986) · Diabetes · doi:10.2337/diab.35.11.1268 · Cited by 159
Self-citation
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Mäkimattila, S., Liu, M., Vakkilainen, J., Schlenzka, A., Lahdenperä, S., Syvänne, M., Mäntysaari, M., Summanen, P. A., Bergholm, R., Taskinen, M., et al. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.973 · Cited by 156
Self-citation
High Density Lipoprotein (HDL) Metabolism in Noninsulin-Dependent Diabetes Mellitus: Measurement of HDL Turnover Using Tritiated HDL*
Golay, A., Zech, L. A., SHI, M.-Z., Chiou, Y.-A. M., Reaven, G. M., & Chen, Y. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-512 · Cited by 154
Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin
Sugden, M. C., Bulmer, K., Gibbons, G. F., Knight, B. L., & Holness, M. J. (2002) · Biochemical Journal · doi:10.1042/bj20011699 · Cited by 152
Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity
Hogikyan, R. V., Gałecki, A. T., Pitt, B., Halter, J. B., Greene, D. A., & Supiano, M. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4907 · Cited by 151
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease
Heine, R. J., & Dekker, J. M. (2002) · Diabetologia · doi:10.1007/s00125-001-0726-0 · Cited by 146
Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100
Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.199 · Cited by 143
Role of the Insulin Receptor Substrate 1 and Phosphatidylinositol 3-Kinase Signaling Pathway in Insulin-Induced Expression of Sterol Regulatory Element Binding Protein 1c and Glucokinase Genes in Rat Hepatocytes
Matsumoto, M., Ogawa, W., Teshigawara, K., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1672 · Cited by 139
Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue‐specific manner
Panarotto, D., Rémillard, P., Bouffard, L., & Maheux, P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00945.x · Cited by 137
Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women
Tan, C., Forster, L. F., CASLAKE, M. J., Bedford, D. K., Watson, T. D. G., McConnell, M., Packard, C. J., & Shepherd, J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1839 · Cited by 137
High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
Syvänne, M., Ahola, M., Lahdenperä, S., Kahri, J., Kuusi, T., Virtanen, K. S., & Taskinen, M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39891-6 · Cited by 133
Self-citation
Endothelial Dysfunction in Men With Small LDL Particles
Vakkilainen, J., Mäkimattila, S., Seppälä‐Lindroos, A., Vehkavaara, S., Lahdenperä, S., Groop, P., Taskinen, M., & Yki‐Järvinen, H. (2000) · Circulation · doi:10.1161/01.cir.102.7.716 · Cited by 133
Self-citation
Intracellular Assembly of VLDL
Olofsson, S.-O., Stillemark-Billton, P., & Asp, L. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00071-8 · Cited by 132
U.K. Prospective Diabetes Study 27: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex
U.K. Prospective Diabetes Study Group (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1683 · Cited by 129
Role of insulin in hepatic fatty acid partitioning: emerging concepts
Zammit, V. A. (1996) · Biochemical Journal · doi:10.1042/bj3140001 · Cited by 125
Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis
de Man, F. H. A. F., Cabezas, M. C., van Barlingen, H. H. J. J., Erkelens, D. W., & de Bruin, T. W. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.114256.x · Cited by 124
Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study
Duvillard, L., Pont, F., Florentin, E., Galland-Jos, C., Gambert, P., & Vergès, B. L. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00755.x · Cited by 123
Phosphoinositide 3-Kinase Activity Is Necessary for Insulin-dependent Inhibition of Apolipoprotein B Secretion by Rat Hepatocytes and Localizes to the Endoplasmic Reticulum
Phung, T. L., Roncone, A. M., Jensen, K. L. D. M., Sparks, C. E., & Sparks, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30693 · Cited by 122
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
Cummings, M. H., Watts, G. F., Umpleby, A. M., Hennessy, T. R., Naoumova, R. P., Slavin, B. M., Thompson, G. R., & S�nksen, P. H. (1995) · Diabetologia · doi:10.1007/bf00400586 · Cited by 121
Hepatic Expression of Microsomal Triglyceride Transfer Protein and In Vivo Secretion of Triglyceride-Rich Lipoproteins Are Increased in Obese Diabetic Mice
Bartels, E. D., Lauritsen, M. L., & Nielsen, L. B. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1233 · Cited by 120
Apolipoproteins C–III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Temoins sur 'Infarctus du Myocarde
Luc, G., Fievet, C., Arveiler, D., Evans, A. E., Bard, J. M., Cambien, F., Fruchart, J. C., & Ducimetiere, P. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37594-5 · Cited by 114
Hepatic steatosis and type 2 diabetes mellitus
Clark, J. M., & Diehl, A. M. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0085-3 · Cited by 108
Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics
BRIONES, E. R., Mao, S. J. T., Palumbo, P. J., O’Fallon, W. M., CHENOWETH, W. L., & Kottke, B. A. (1984) · Metabolism · doi:10.1016/0026-0495(84)90160-4 · Cited by 107
Identification of the Proteoglycan Binding Site in Apolipoprotein B48
Flood, C., Gustafsson, M. V., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 107
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein
Syvänne, M., Castro, G., Dengremont, C., Geitere, C. D., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J., & Taskinen, M. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05962-x · Cited by 105
Self-citation
Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians
Gray, R. S., Robbins, D. C., Wang, W., Yeh, J. L., Fabsitz, R. R., Cowan, L. D., Welty, T. K., Lee, E. T., Krauss, R. M., & Howard, B. V. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2713 · Cited by 104
A Tailored Therapy for the Metabolic Syndrome
Etgen, G. J., Oldham, B. A., Johnson, W. T., Broderick, C. L., Montrose, C., Brozinick, J. T., Misener, E. A., Bean, J. S., Bensch, W. R., Brooks, D. A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1083 · Cited by 104
Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides
Lahdenper, S., Syv�nne, M., Kahri, J., & Taskinen, M. (1996) · Diabetologia · doi:10.1007/bf00400677 · Cited by 103
Self-citation
Effect of Insulin Therapy on Metabolic Fate of Apolipoprotein B–Containing Lipoproteins in NIDDM
Taskinen, M., Packard, C. J., & Shepherd, J. (1990) · Diabetes · doi:10.2337/diab.39.9.1017 · Cited by 103
Self-citation
Ectopic fat accumulation: an important cause of insulin resistance in humans.
Yki‐Järvinen, H. (2002) · Europe PMC (PubMed Central) · Cited by 101
The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes
Baynes, C., Henderson, A. D., Anyaoku, V., Richmond, W., Hughes, C. L., Johnston, D. G., & Elkeles, R. S. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01652.x · Cited by 99
Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster
Carpentier, A. C., Taghibiglou, C., Leung, N. M., Szeto, L., Iderstine, S. C. V., Uffelman, K. D., Buckingham, R. E., Adeli, K., & Lewis, G. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204568200 · Cited by 97
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Syvänne, M., Hilden, H., & Taskinen, M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40121-x · Cited by 97
Self-citation
Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation
Rashid, S., Barrett, P. H. R., Uffelman, K. D., Watanabe, T., Adeli, K., & Lewis, G. F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105374 · Cited by 96
Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus
Ginsberg, H. N., & Illingworth, D. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01831-8 · Cited by 94
Insulin Inhibits the Maturation Phase of VLDL Assembly via a Phosphoinositide 3-Kinase—Mediated Event
Brown, A.-M., & Gibbons, G. F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096640 · Cited by 93
Influence of Peroxisome Proliferator-activated Receptor α Agonists on the Intracellular Turnover and Secretion of Apolipoprotein (Apo) B-100 and ApoB-48
Lindén, D., Lindberg, K., Oscarsson, J., Claesson, C., Asp, L., Lu, L., Gustafsson, M. V., Borén, J., & Olofsson, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110416200 · Cited by 92
Phospholipase A2 and small, dense low-density lipoprotein
Hurt‐Camejo, E., Camejo, G., & Sartipy, P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00004 · Cited by 90
Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation
Kuriyama, H., Yamashita, S., Shimomura, I., Funahashi, T., Ishigami, M., Aragane, K., Miyaoka, K., Nakamura, T., Takemura, K., Man, Z., et al. (1998) · Hepatology · doi:10.1002/hep.510270233 · Cited by 90
Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
Stewart, M. W., Laker, M. F., Dyer, R. G., Game, F. L., Mitcheson, J., Winocour, P. H., & Alberti, K. G. M. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1046 · Cited by 89
Interaction of native and modified low-density lipoproteins with extracellular matrix
Chait, A., & Wight, T. N. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00003 · Cited by 87
Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production
Chirieac, D. V., Chirieac, L. R., Corsetti, J. P., Cianci, J., Sparks, C. E., & Sparks, J. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1003 · Cited by 87
In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch, J., Julius, U., Nitzsche, S., & Markolf Hanefeld, E. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1928 · Cited by 86
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I. J., & Shachter, N. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8283 · Cited by 86
Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes
Gervaise, N., Garrigue, M. A., Lasfargues, G., & Lecomte, P. (2000) · Diabetologia · doi:10.1007/s001250051366 · Cited by 82
Influence of Low Density Lipoprotein (LDL) Subfraction Profile and LDL Oxidation on Endothelium-Dependent and Independent Vasodilation in Patients with Type 2 Diabetes
Tan, K. C. B., Ai, V. H. G., Chow, W.-S., Chau, M. T., Leong, L. L. Y., & Lam, K. S. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5959 · Cited by 81
Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants
Karpe, F., Olivecrona, T., Hamsten, A., & Hultin, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37219-9 · Cited by 80
Cholesteryl Ester Hydroperoxide Lability Is a Key Feature of the Oxidative Susceptibility of Small, Dense LDL
Chancharme, L., Thérond, P., Nigon, F., Lepage, S., Couturier, M., & Chapman, M. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.810 · Cited by 80
High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study
Frénais, R., Ouguerram, K., Maugeais, C., Mahot, P., Maugère, P., Krempf, M., & Magot, T. (1997) · Diabetologia · doi:10.1007/s001250050718 · Cited by 79
Optimization of Glycemic Control by Insulin Therapy Decreases the Proportion of Small Dense LDL Particles in Diabetic Patients
Caixàs, A., Ordóñez‐Llanos, J., de Leiva, A., Payés, A., Homs, R., & Pérez, A. (1997) · Diabetes · doi:10.2337/diab.46.7.1207 · Cited by 79
Pleiotropic effects of statins: do they matter?
Gotto, A. M., & Farmer, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00004 · Cited by 77
Role of extracellular retention of low density lipoproteins in atherosclerosis
Borén, J., Gustafsson, M. V., Skålén, K., Flood, C., & Innerarity, T. L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00002 · Cited by 75
Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism
Tu, A.-Y., & Albers, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1851 · Cited by 75
Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia
Campos, H., Perlov, D., Khoo, C., & Sacks, F. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31574-1 · Cited by 73
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis
TOMKIN, G. H., & Owens, D. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.179 · Cited by 71
Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes
Koba, S., Hirano, T., Yoshino, G., Sakai, K., Sakaue, T., Adachi, M., & Katagiri, T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00580-9 · Cited by 69
HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
Syvänne, M., Kahri, J., Virtanen, K. S., & Taskinen, M. (1995) · Circulation · doi:10.1161/01.cir.92.3.364 · Cited by 64
Self-citation
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors
Marsh, J. B., Welty, F. K., Lichtenstein, A. H., Lamon‐Fava, S., & Schaefer, E. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00709-2 · Cited by 63
Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1631 · Cited by 59
Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes
Vakkilainen, J., Mero, N., Schweizer, A., Foley, J. E., & Taskinen, M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.324 · Cited by 53
Self-citation
Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation
McEneny, J., O’Kane, M., Moles, K. W., McMaster, C., McMaster, D., Mercer, C., Trimble, E. R., & Young, I. S. (2000) · Diabetologia · doi:10.1007/s001250051333 · Cited by 52
Pathogenesis of dyslipidemia in type 2 diabetes
Taskinen, M. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18580 · Cited by 52
Self-citation
Significance of Hepatic Triglyceride Lipase Activity in the Regulation of Serum High Density Lipoproteins in Type II Diabetes Mellitus*
Kasim, S. E., Tseng, K. H., Jen, K. ‐. C., & Khilnani, S. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-183 · Cited by 50
Differential Metabolism of Human VLDL According to Content of ApoE and ApoC-III
Tomiyasu, K., Walsh, B. W., Ikewaki, K., Judge, H., & Sacks, F. M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.094489 · Cited by 49
Composition of serum very-low-density and high-density lipoproteins in diabetes.
Gabor, J., Spain, M., & Kalant, N. (1980) · Clinical Chemistry · doi:10.1093/clinchem/26.9.1261 · Cited by 48
Lipoprotein correlates of LDL particle size
Rainwater, D. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00216-6 · Cited by 48
LDL Size Distribution in Relation to Insulin Sensitivity and Lipoprotein Pattern in Young and Healthy Subjects
Ambrosch, A., Mühlen, I., Kopf, D., Augustus, W., Dierkes, J., König, W., Luley, C. H., & Lehnert, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2077 · Cited by 46
Responses to eating: lipoproteins, lipolytic products and atherosclerosis
Goldberg, I. J., Kako, Y., & Lutz, E. P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00003 · Cited by 46
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes
Lahdenperä, S., Sane, T., Vuorinen-Markkola, H., Knudsen, P., & Taskinen, M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05450-w · Cited by 43
Self-citation
In VivoEvidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus1
Frénais, R., Nazih, H., Ouguerram, K., Maugeais, C., Zaïr, Y., Bard, J., Charbonnel, B. H., Magot, T., & Krempf, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7480 · Cited by 43
Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus
Tan, K. C. B., Shiu, S. W. M., & Chu, B. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00077-5 · Cited by 42
Sensitivity to Acute Insulin-Mediated Suppression of Plasma Free Fatty Acids Is Not a Determinant of Fasting VLDL Triglyceride Secretion in Healthy Humans
Carpentier, A. C., Patterson, B. W., Leung, N. M., & Lewis, G. F. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1867 · Cited by 41
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials
Armitage, J., & Collins, R. (2000) · Heart · doi:10.1136/heart.84.4.357 · Cited by 41
Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM
Taskinen, M., Packard, C. J., & Shepherd, J. (1990) · Diabetes · doi:10.2337/diabetes.39.9.1017 · Cited by 40
Self-citation
Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects
Bioletto, S., Golay, A., Munger, R., Kalix, B., & James, R. W. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.443 · Cited by 39
Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: Effects of obesity and non-insulin-dependent diabetes mellitus
Howard, B. V., Abbott, W. G. H., Egusa, G., & Taskinen, M. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90625-9 · Cited by 39
Self-citation
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
Mero, N., Suurinkeroinen, L., Syvänne, M., Knudsen, P., Yki‐Järvinen, H., & Taskinen, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33412-x · Cited by 38
Self-citation
Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins
Dimitriadis, E., Griffin, M., Collins, P. B., Johnson, A., Owens, D., & TOMKIN, G. (1996) · Diabetologia · doi:10.1007/bf00418538 · Cited by 34
Is the fatty meal a trigger for acute coronary syndromes.
Anderson, R. A., Jones, C., & Goodfellow, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00669-4 · Cited by 34
Reduced IGFBP-1 Is Associated With Thickening of the Carotid Wall in Type 2 Diabetes
Leinonen, E. S., Salonen, J. T., Salonen, R. M., Koistinen, R. A., Leinonen, P. J., Sarna, S. J., & Taskinen, M. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1807 · Cited by 34
Self-citation
Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects
Malmström, R., Packard, C. J., CASLAKE, M. J., Bedford, D. K., Stewart, P., Shepherd, J., & Taskinen, M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00153-7 · Cited by 32
Self-citation
Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
Tilly-Kiesi, M., Syvänne, M., Kuusi, T., Lahdenperä, S., & Taskinen, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41523-8 · Cited by 31
Self-citation
Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report
Syvänne, M., Rossened, M., Labeur, C., Hilden, H., & Taskinen, M. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90004-3 · Cited by 28
Self-citation
Genetic determinants of plasma triglycerides: impact of rare and common mutations
Talmud, P. J. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0061-4 · Cited by 27
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2)
Kornerup, K., Nordestgaard, B. G., Feldt‐Rasmussen, B., Borch‐Johnsen, K., Jensen, K. S., & Jensen, J. S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022849.26083.fa · Cited by 27
Apolipoprotein C in Type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia
Stalenhoef, A. F. H., Demacker, P. N. M., Lutterman, J. A., & Laar, A. V. (1982) · Diabetologia · doi:10.1007/bf00282597 · Cited by 23
Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well‐controlled type 2 diabetes
Scheffer, P. G., Bakker, S. J. L., Popp‐Snijders, C., Heine, R. J., Schutgens, R. B. H., & Teerlink, T. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.231 · Cited by 20
Increased ABCA1 activity protects against atherosclerosis
Singaraja, R. R., Fiévet, C., Castro, G. R., James, E. R., Hennuyer, N., Clee, S. M., Bissada, N., Choy, J. C., Fruchart, J., McManus, B. M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215748 · Cited by 19
Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus.
Ishibashi, S., Yamada, N., Shimano, H., Takaku, F., Akanuma, Y., & Murase, T. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.5.808 · Cited by 12
Triglycerides and endothelial function in type 2 diabetes
Rongen, G. A. P. J. M., & Tack, C. J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00854.x · Cited by 9
Coronary heart disease in patients with low LDL-cholesterol. Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors
Sacks, F. M., Tonkin, A. M., & Craven, T. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00773-0 · Cited by 9
Triglyceride-Rich Lipoproteins from Subjects with Type 2 Diabetes Do Not Demonstrate Increased Binding to Biglycan, a Vascular Proteoglycan
Tannock, L. R., Olin, K. L., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8190 · Cited by 8

Sorted by citations

Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“hyperinsulinemia, abnormalities in adipokines and adipocytokines have been implicated [190].”
Background
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67667-2 · Cited by 3,284
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215

See all 888

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks